MARBUNG VIRUS - SCI & TECH

News: Marbung virus disease outbreak kills five in Tanzania

 

What's in the news?

       Five people have died and three others are infected with the Marburg virus – a highly infectious, Ebola-like disease – in Tanzania’s north-west Kagera region, authorities said earlier this week.

 

Key takeaways:

       According to the World Health Organization (WHO), around 161 people have been identified as at risk of infection through contact tracing and are currently being monitored.

 

Marbung Virus:

       Marburg virus disease (MVD), earlier known as Marburg haemorrhagic fever, is a severe, often fatal hemorrhagic fever, according to the WHO.

       Marburg, like Ebola, is a filovirus; and both diseases are clinically similar.

       Rousettus fruit-bats are considered the natural hosts for Marburg virus.

       However, African green monkeys imported from Uganda were the source of the first human infection, the WHO points out.

       It was first detected in 1967 after simultaneous outbreaks in Marburg and Frankfurt in Germany; and in Belgrade, Serbia.

       The disease has an average fatality rate of around 50%. However, it can be as low as 24% or as high as 88% depending on virus strain and case management, says the WHO.

 

Symptoms:

       After the onset of symptoms, which can begin anytime between 2 to 21 days, MVD can manifest itself in the form of high fever, muscle aches and severe headache.

       Around the third day, patients report abdominal pain, vomiting, severe watery diarrhoea and cramping.

       In this phase, the WHO says, the appearance of patients has been often described as “ghost-like” with deep-set eyes, expressionless faces, and extreme lethargy.

 

Diagnosis and Treatment:

       It is difficult to clinically distinguish MVD from diseases such as malaria, typhoid fever and other viral haemorrhagic fevers.

       However, it is confirmed by lab testing of samples, which like Coronavirus and Ebola are extreme biohazard risk.

       There is no approved antiviral treatment or vaccine for MVD as of now. It can be managed with supportive care.

       According to the WHO, rehydration with oral or intravenous fluids, and treatment of specific symptoms can help prevent death.